Download PDF
Klin Padiatr 2019; 231(05): 240-247
DOI: 10.1055/a-0963-0293
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Non-CF Bronchiectasis as a Possible Indicator of a Primary Immunodeficiency: Diagnosis, Clinical Course, and Quality of Life in a Pediatric Cohort

Nicht-CF Bronchiektasen als möglicher Hinweis für einen zugrundeliegenden primären Immundefekt: Diagnose, Verlauf und Lebensqualität
Christian Klemann
1   Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover
,
Kinga Beata Kellermann
2   Center for Pediatrics – Department of general pediatrics, adolescent medicine and neonatology, University Medical Center Freiburg, Freiburg
,
Stephan Ehl
3   Center for Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg
,
Martin Stenzel
4   Pediatric radiology department, Childrenʼs Hospital Amsterdamer Strasse, Köln
,
Christoph Mueller
2   Center for Pediatrics – Department of general pediatrics, adolescent medicine and neonatology, University Medical Center Freiburg, Freiburg
,
Andrea Heinzmann
2   Center for Pediatrics – Department of general pediatrics, adolescent medicine and neonatology, University Medical Center Freiburg, Freiburg
,
Sebastian Felix Nepomuk Bode
2   Center for Pediatrics – Department of general pediatrics, adolescent medicine and neonatology, University Medical Center Freiburg, Freiburg
› Author Affiliations
Further Information

Publication History

Publication Date:
24 July 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Background Non cystic fibrosis bronchiectasis (NCBE) is an increasingly recognized chronic, progressive respiratory disorder with significant morbidity also in children and adolescents.

Methods We longitudinally assessed a cohort of 35 pediatric patients with NCBE and investigated underlying diagnosis, symptoms, clinical course, treatment, and quality of life.

Results NCBE were diagnosed at a mean age of 9.5 (±5.3) years. In half of the children NCBE were found prior to identification of the causative diagnosis. Primary immunodeficiency (PID) was identified as the underlying diagnosis in 24/35 (68%) cases, of which two-thirds showed antibody deficiency. In the 11 non-PID cases ciliopathies were most common (n=7). Clinical aspects such as manifestation age, cough or dyspnea symptoms, and exacerbation frequency did not differ significantly between PID and non-PID patients. Likewise, quality of life (QoL) was equally reduced in both groups. Lung function test parameters were stable under appropriate therapy in all children. The majority in both groups was insufficiently vaccinated against influenza and pneumococci.

Conclusion Our data indicates that NCBE need to be especially appreciated as a presenting sign of PID in pediatric patients. Thus, occurrence of NCBE should warrant rigorous diagnostics to identify the underlying condition. In our cohort NCBE themselves rather than the causative diagnoses seem to dictate the clinical course of disease and reduce QoL in children. More intensive efforts have to be undertaken to vaccinate patients according to recommendations.

Zusammenfassung

Hintergrund Nicht zystische Fibrose assoziierte Bronchiektasen (NCBE) sind eine zunehmend diagnostizierte chronische, progressive Atemwegserkrankung mit signifikanter Morbidität auch bei Kindern und Jugendlichen.

Methoden Eine Kohorte von 35 Kindern wurde longitudinal hinsichtlich der zugrunde liegende Diagnose, Symptome, klinischem Verlauf, Behandlung und Lebensqualität untersucht.

Ergebnisse NCBE wurden im Mittel im Alter von 9,5 Jahren (± 5,3) diagnostiziert. In der Hälfte der Fälle erfolge der NCBE Nachweis bevor eine zugrunde liegende Diagnose gestellt werden konnte. Primäre Immundefekte (PID) wurden bei 24/35 Patienten (68 %) identifiziert. Von diesen wiesen zwei Drittel einen Antikörpermangel auf. Primäre ziliäre Dyskinesie (n = 7) war die häufigste Diagnose in der Nicht-PID Gruppe (n = 11). PID- und Nicht-PID-Patienten zeigten keinen signifikanten Unterschied bezüglich Manifestationsalter, Husten, Dyspnoe und die Exazerbationsfrequenz. Die Lebensqualität war in beiden Gruppen gleichermaßen reduziert. Lungenfunktionstest-Parameter waren bei entsprechender Therapie bei allen Kindern stabil. Die Mehrheit der Patienten in beiden Gruppen war unzureichend gegen Influenza und Pneumokokken geimpft.

Zusammenfassung NCBE sollten als Manifestationszeichen von PID bei pädiatrischen Patienten wahrgenommen werden und sollten eine rigorose Diagnostik nach sich ziehen, um die zugrunde liegende Erkrankung zu identifizieren. In unserer Kohorte scheinen NCBE selbst und nicht die ursächliche Diagnose den Verlauf der Erkrankung und die Lebensqualität zu beeinflussen. Intensivere Anstrengungen sollten unternommen werden, um Patienten mit NCBE entsprechend der Empfehlungen zu impfen.

Key words

bronchiectasis - non-CF - immunodeficiency - quality of life

Schlüsselwörter

Bronchiektasen - Nicht-CF - Immundefekt - Lebensqualität

Ergänzendes Material

    Supplemental Table 1 and Supplemental Fig. 1 are availabe under https://doi.org/10.1055/a-0963-0293
  • Ergänzendes Material
 

  • References

  • 1 Aliberti S, Lonni S, Dore S. et al. Clinical phenotypes in adult patients with bronchiectasis. Eur Respir J 2016; 47: 1113-1122
    CrossrefPubMedGoogle Scholar
  • 2 Anwar GA, McDonnell MJ, Worthy SA. et al. Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study. Respir Med 2013; 107: 1001-1007
    CrossrefPubMedGoogle Scholar
  • 3 Behan L, Dimitrov BD, Kuehni CE. et al. PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia. Eur Respir J 2016; 47: 1103-1112
    CrossrefPubMedGoogle Scholar
  • 4 Bode SFN, Hufnagel M, Speckmann C. Impfungen bei Immunsuppression und bei immunkompromittierten Patienten. pädiat prax 2012; 79: 647-657
    PubMedGoogle Scholar
  • 5 Bousfiha A, Jeddane L, Picard C. et al. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. J Clin Immunol 2018; 38: 129-143
    CrossrefPubMedGoogle Scholar
  • 6 Brower KS, Del Vecchio MT, Aronoff SC. The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects. BMC Pediatr 2014; 14: 4
    CrossrefPubMedGoogle Scholar
  • 7 Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet 2018; 392: 866-879
    CrossrefPubMedGoogle Scholar
  • 8 Chang AB, Oppenheimer JJ, Weinberger M. et al. Use of Management Pathways or Algorithms in Children With Chronic Cough: Systematic Reviews. Chest 2016; 149: 106-119
    CrossrefPubMedGoogle Scholar
  • 9 Dodd JD, Lavelle LP, Fabre A. et al. Imaging in cystic fibrosis and non-cystic fibrosis bronchiectasis. Semin Respir Crit Care Med 2015; 36: 194-206
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Eastham KM, Fall AJ, Mitchell L. et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004; 59: 324-327
    CrossrefPubMedGoogle Scholar
  • 11 Gallucci M, di Palmo E, Bertelli L. et al. A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age. Ital J Pediatr 2017; 43: 117
    CrossrefPubMedGoogle Scholar
  • 12 Giron RM, de Gracia Roldan J, Olveira C. et al. Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis. Chron Respir Dis 2017; 14: 360-369
    CrossrefPubMedGoogle Scholar
  • 13 Gokdemir Y, Hamzah A, Erdem E. et al. Quality of life in children with non-cystic-fibrosis bronchiectasis. Respiration 2014; 88: 46-51
    CrossrefPubMedGoogle Scholar
  • 14 Gonem S, Scadding A, Soares M. et al. Lung clearance index in adults with non-cystic fibrosis bronchiectasis. Respir Res 2014; 15: 59
    CrossrefPubMedGoogle Scholar
  • 15 Hnin K, Nguyen C, Carson KV. et al. Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults. Cochrane Database Syst Rev 2015; DOI: 10.1002/14651858.CD001392.pub3:. CD001392
    CrossrefPubMedGoogle Scholar
  • 16 Kapur N, Grimwood K, Masters IB. et al. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol 2012; 47: 300-307
    CrossrefPubMedGoogle Scholar
  • 17 Kapur N, Karadag B. Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countries. Paediatr Respir Rev 2011; 12: 91-96
    CrossrefPubMedGoogle Scholar
  • 18 Kapur N, Mackay IM, Sloots TP. et al. Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children. Arch Dis Child 2014; 99: 749-753
    CrossrefPubMedGoogle Scholar
  • 19 Kapur N, Masel JP, Watson D. et al. Bronchoarterial ratio on high-resolution CT scan of the chest in children without pulmonary pathology: need to redefine bronchial dilatation. Chest 2011; 139: 1445-1450
    CrossrefPubMedGoogle Scholar
  • 20 Kapur N, Masters IB, Chang AB. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?. Chest 2010; 138: 158-164
    CrossrefPubMedGoogle Scholar
  • 21 Li AM, Sonnappa S, Lex C. et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?. Eur Respir J 2005; 26: 8-14
    CrossrefPubMedGoogle Scholar
  • 22 Lourdesamy Anthony AI, Muthukumaru U. Efficacy of azithromycin in the treatment of bronchiectasis. Respirology 2014; 19: 1178-1182
    CrossrefPubMedGoogle Scholar
  • 23 Martinez-Garcia MA, Vendrell M, Giron R. et al. The Multiple Faces of Non-Cystic Fibrosis Bronchiectasis. A Cluster Analysis Approach. Ann Am Thorac Soc 2016; 13: 1468-1475
    CrossrefPubMedGoogle Scholar
  • 24 McDonnell MJ, Ward C, Lordan JL. et al. Non-cystic fibrosis bronchiectasis. QJM 2013; 106: 709-715
    CrossrefPubMedGoogle Scholar
  • 25 McShane PJ, Naureckas ET, Tino G. et al. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2013; 188: 647-656
    CrossrefPubMedGoogle Scholar
  • 26 Montella S, Maglione M, Bruzzese D. et al. Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease. Respirology 2012; 17: 87-91
    CrossrefPubMedGoogle Scholar
  • 27 Munro KA, Reed PW, Joyce H. et al. Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?. Pediatr Pulmonol 2011; 46: 131-138
    CrossrefPubMedGoogle Scholar
  • 28 Murray MP, Pentland JL, Hill AT. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J 2009; 34: 1086-1092
    CrossrefPubMedGoogle Scholar
  • 29 Nathan AM, de Bruyne JA, Eg KP. et al. Review: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis. Front Pediatr 2017; 5: 84
    CrossrefPubMedGoogle Scholar
  • 30 Neri L, Lucidi V, Catastini P. et al. Caregiver burden and vocational participation among parents of adolescents with CF. Pediatr Pulmonol 2016; 51: 243-252
    CrossrefPubMedGoogle Scholar
  • 31 Pasteur MC, Bilton D, Hill AT. et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65: 577
    CrossrefPubMedGoogle Scholar
  • 32 Patria MF, Longhi B, Lelii M. et al. Children with recurrent pneumonia and non-cystic fibrosis bronchiectasis. Ital J Pediatr 2016; 42: 13
    CrossrefPubMedGoogle Scholar
  • 33 Pellegrino R, Viegi G, Brusasco V. et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968
    CrossrefPubMedGoogle Scholar
  • 34 Quanjer PH, Stanojevic S, Cole TJ. et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: The global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343
    CrossrefPubMedGoogle Scholar
  • 35 Rogers GB, Bruce KD, Martin ML. et al. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: An analysis from the randomised, double-blind, placebo-controlled BLESS trial. Lancet Respir Med 2014; 2: 988-996
    CrossrefPubMedGoogle Scholar
  • 36 Santamaria F, Montella S, Pifferi M. et al. A descriptive study of non-cystic fibrosis bronchiectasis in a pediatric population from central and southern Italy. Respiration 2009; 77: 160-165
    CrossrefPubMedGoogle Scholar
  • 37 Schmidt A, Wenninger K, Niemann N. et al. Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R. Health Qual Life Outcomes 2009; 7: 97
    CrossrefPubMedGoogle Scholar
  • 38 Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007; 101: 1163-1170
    CrossrefPubMedGoogle Scholar
  • 39 Werner C, Onnebrink JG, Omran H. Diagnosis and management of primary ciliary dyskinesia. Cilia 2015; 4: 2
    CrossrefPubMedGoogle Scholar
  • 40 Zapletal A. Lung Function in Children and Adolescents: Methods, reference values Prague. Karger; 1987
    Google Scholar